Drug Policy Archives - Page 3 of 56

Psychedelics Policy Newsletter: RFK Jr. gives hopeful approval timeline, Arizona advances ibogaine, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — August 2025

Commentary by Gregory Ferenstein

Arizona joins Texas in ibogaine clinical trial research push for veteran, first responder mental health

Commentary by Leonard Gilroy

Healthy families start with compassionate policy: Addressing drug use during pregnancy

Commentary by Layal Bou Harfouch

Reducing harm, saving lives: The case for supervised drug consumption sites

Commentary by Layal Bou Harfouch

Hemp in Texas: Regulation—not THC prohibition—is the sensible path forward  

Commentary by Michelle Minton

Psychedelics Policy Newsletter: FDA prioritizes drug reform for psychedelics, Texas advances ibogaine research, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — June 2025

Commentary by Gregory Ferenstein

Trump’s proposed price controls on Medicare and Medicaid could reduce government spending

Commentary by Jacob James Rich

More Drug Policy

Prev
1
2
3
4
5
6
7
...
56
Next